Allscripts (MDRX) Posts Stronger Q3 Results; Guides FY10, Q410 EPS, Revs
Tweet Send to a FriendGet Alerts MDRX Hot Sheet
Trade MDRX Now!
Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) reports Q3 adjusted EPS of $0.19, versus $0.16 reported for the same period a year ago. Revenue for the quarter was $242.4 million, compared to $164.9 million in Q309.
Sees Q410 EPS of $0.18 - $0.19, and sales $332 - $337 million
Sees FY11 EPS of $0.85 - $0.89 and sales of $1.43 - $1.45 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees Q410 EPS of $0.18 - $0.19, and sales $332 - $337 million
Sees FY11 EPS of $0.85 - $0.89 and sales of $1.43 - $1.45 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
- Zumiez, Inc. (ZUMZ) Tops Q1 EPS by 1c; Guides In-Line
Create E-mail Alert Related Categories
Earnings, Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
